Diagnostics of breast cancer are necessary for early breast cancer detection. A thorough knowledge about the disease is necessary to provide a proper treatment. This also helps the family members cope with the stress brought by the diagnosis. There are many different kinds of tests available for breast cancer.
The Diagnostic and Statistical Manual of Mental Disorders (DSM) published by the American Psychiatric Association, 4th edition, states that all of the following must be present in clinical diagnostics of breast cancer: tumor, mass on the tumor or surrounding structures, lymph node involvement, and detection of inflammatory cells in the lymph nodes. Tumors must be apparent and large enough to be visualized on a mammogram. Mass on the tumor or surrounding structures must be evident either by touch or with palpation. lymph node involvement should be the only method of detection. Other than these criteria, diagnostics of breast cancer need additional testing such as a blood test or biopsy to clarify whether cancerous cells are present.
Most recent advances in medical science have enabled cancer specialists to perform breast cancer tests using a combination of radiological, immunohistochemical, and molecular techniques. These new methods of diagnostics of breast cancer can help in predicting the type of tumor and in treating the disease at its earliest stages. Some of the advanced methods of diagnostics of breast cancer include; digital rectal exam, mammography, magnetic resonance imaging, cryosurgery, and administration of a hormonal drug known as aromatase inhibitors.
Radiologic diagnostics of breast cancer utilizes magnetic-particle studies and Computer assisted tomography (CT) or magnetic resonance imaging to obtain images of the tumor. These diagnostic methods of diagnostics of breast cancer are based on the concept of blood cell production related parameters. The most widely used parameters are the number of myeloid cells, the lymphocytic rate, and the ratio of lymphocytes to corpuscles. Blood tests that measure these parameters are used in conjunction with pathologists or oncologists.
Immunohistochemical techniques of diagnostics of breast cancer are used to identify antibodies that can attack the tumor. These antibodies are derived from human leukocytes or lymphomas that can bind with the tumor and destroy it. These blood markers can provide key information regarding the spread of the tumor. A molecular probe that binds to the tumor and releases DNA into the blood helps to determine the type of tumor. These tests are very accurate and often require a biopsy of the tumor in order to provide conclusive results. Tumors that are difficult to remove and do not lie within the breast fold are more difficult to analyze using this method.
In clinical settings, the use of molecular probes for diagnostics of breast cancer is most commonly done on patients who have been treated with hormonal therapy or with surgery for the cancer. A molecular probe is used to reveal the presence of antibody-antibodies bound to the tumor and to identify whether the tumor has spread to other parts of the body. These tests can be very revealing and can determine whether surgery should be recommended. If surgery is decided upon at this point, it will almost always have a significant clinical outcome.
As a matter of fact, clinical outcomes for diagnostics of breast cancer diagnostics market are very encouraging. Indeed, the market is booming with a number of clinical trials currently underway. For patients who are experiencing this condition, good treatment options are possible and there are no drastic mortality rates seen in those who receive a cure for the disease.
There is still a long way to go in diagnostics of breast cancer diagnostics market. However, the potential of a cure for this common health problem is greatly promising. The use of molecular biology tools and techniques will continue to emerge and improve. Only time will tell whether these tools will prove useful in the future.